USPH Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . US Physicalrapy
USPH Stock  USD 83.25  0.22  0.26%   
US Physicalrapy's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing US Physicalrapy's valuation are provided below:
Gross Profit
171 M
Profit Margin
0.0512
Market Capitalization
1.3 B
Enterprise Value Revenue
2.0294
Revenue
773.3 M
We have found one hundred twenty available fundamental measures for US Physicalrapy, which can be analyzed and compared to other ratios and to its peers in the sector. Traders should compare all of US Physicalrapy latest fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The US Physicalrapy's current Market Cap is estimated to increase to about 165.1 M. The US Physicalrapy's current Enterprise Value is estimated to increase to about 151.5 M

US Physicalrapy Total Revenue

820.04 Million

Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.9 M, Total Revenue of 820 M or Gross Profit of 165.2 M, as well as many indicators such as Price To Sales Ratio of 2.93, Dividend Yield of 0.0198 or PTB Ratio of 4.6. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
  
Build AI portfolio with USPH Stock
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

US Physicalrapy Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.3 B1.2 B570.3 M
Slightly volatile
Other Current Liabilities85 M81 M36.2 M
Slightly volatile
Total Current Liabilities146 M139 M60.8 M
Slightly volatile
Total Stockholder Equity500.3 M476.4 M255.4 M
Slightly volatile
Property Plant And Equipment Net284.6 M271.1 M84.6 M
Slightly volatile
Accounts Payable6.4 M6.1 M3.2 M
Slightly volatile
Cash19.7 M35.6 M29.3 M
Slightly volatile
Non Current Assets Total1.1 B1.1 B481 M
Slightly volatile
Cash And Short Term Investments19.7 M35.6 M29.3 M
Slightly volatile
Net Receivables67.5 M64.2 M47.9 M
Slightly volatile
Common Stock Shares Outstanding13.1 M15.2 M12.7 M
Slightly volatile
Liabilities And Stockholders Equity1.3 B1.2 B570.3 M
Slightly volatile
Other Current Assets42.2 M40.2 M12.4 M
Slightly volatile
Other Stockholder Equity260.7 M248.3 M102.9 M
Slightly volatile
Total Liabilities455.5 M433.8 M192.4 M
Slightly volatile
Property Plant And Equipment Gross305.7 M291.1 M100.6 M
Slightly volatile
Total Current Assets147 M140 M89.3 M
Slightly volatile
Short and Long Term Debt Total447 M425.7 M148 M
Slightly volatile
Non Current Liabilities Total309.5 M294.8 M131.6 M
Slightly volatile
Short Term Debt54.6 M52 M20.2 M
Slightly volatile
Intangible Assets181.5 M172.9 M69.1 M
Slightly volatile
Good Will657.8 M692.4 M922.3 T
Slightly volatile
Common Stock Total Equity144.3 K173.7 K142.2 K
Slightly volatile
Common Stock150.2 K174 K145.1 K
Slightly volatile
Other Assets2.1 M1.9 M2.2 M
Pretty Stable
Long Term Debt172.1 M163.9 M76.2 M
Slightly volatile
Property Plant Equipment154.3 M146.9 M58.1 M
Slightly volatile
Current Deferred Revenue1.9 M3.3 M2.7 M
Very volatile
Other Liabilities41.5 M39.5 M16.5 M
Slightly volatile
Long Term Debt Total142 M135.2 M68.4 M
Slightly volatile
Capital Surpluse73.5 M118.1 M73.5 M
Slightly volatile
Non Current Liabilities Other22.1 M21 M6.9 M
Slightly volatile
Warrants106 M178.6 M91.1 M
Slightly volatile
Short and Long Term Debt13.3 M12.6 M4.2 M
Slightly volatile
Net Invested Capital452.3 M738.8 M372.9 M
Slightly volatile
Capital Stock172.4 K197.8 K156.4 K
Slightly volatile
Capital Lease Obligations118.5 M163 M100.5 M
Slightly volatile

US Physicalrapy Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue820 M781 M437.9 M
Slightly volatile
Gross Profit165.2 M157.3 M95.6 M
Slightly volatile
Other Operating Expenses735.6 M700.6 M385.2 M
Slightly volatile
Cost Of Revenue654.8 M623.6 M342.4 M
Slightly volatile
Total Operating Expenses80.8 M76.9 M42.8 M
Slightly volatile
Income Tax Expense20.8 M19.8 M12.6 M
Slightly volatile
Depreciation And Amortization23.5 M22.4 M11 M
Slightly volatile
Income Before Tax81.7 M77.8 M51.5 M
Slightly volatile
Selling General Administrative70.4 M67 M39.9 M
Slightly volatile
Net Income Applicable To Common Shares19.8 M33.7 M25.5 M
Slightly volatile
Net Income From Continuing Ops42.9 M52.4 M39.4 M
Slightly volatile
Non Recurring4.7 M4.9 M4.3 M
Slightly volatile
Non Operating Income Net Other2.3 M2.9 M2.5 M
Pretty Stable
Tax Provision13.6 M16.8 M13.1 M
Pretty Stable
Interest Income3.7 M3.5 M3.5 M
Slightly volatile
Reconciled Depreciation13.8 M21.5 M12 M
Slightly volatile
Extraordinary Items3.4 M3.9 M4.2 M
Slightly volatile
Selling And Marketing Expenses7.6 M8.6 M9.4 M
Slightly volatile

US Physicalrapy Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures14.8 M14.1 M7.5 M
Slightly volatile
End Period Cash Flow19.7 M35.6 M29.3 M
Slightly volatile
Begin Period Cash Flow43.4 M41.4 M29.1 M
Slightly volatile
Depreciation23.5 M22.4 M11 M
Slightly volatile
Stock Based Compensation4.9 M8.3 M5.4 M
Slightly volatile
Dividends Paid14 M27.4 M13 M
Slightly volatile
Change To Netincome39.9 M38 M20.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.931.51733.5845
Slightly volatile
Dividend Yield0.01980.02310.0167
Pretty Stable
PTB Ratio4.62.48734.1291
Pretty Stable
Days Sales Outstanding28.5330.027142.266
Slightly volatile
Book Value Per Share53.2950.754527.8124
Slightly volatile
Stock Based Compensation To Revenue0.0090.01060.012
Slightly volatile
Capex To Depreciation1.050.62840.755
Pretty Stable
PB Ratio4.62.48734.1291
Pretty Stable
EV To Sales2.872.01693.5669
Slightly volatile
ROIC0.0510.05370.0973
Slightly volatile
Payables Turnover88.44103123
Very volatile
Sales General And Administrative To Revenue0.120.09980.0986
Slightly volatile
Capex To Revenue0.01710.0180.0358
Slightly volatile
Cash Per Share2.462.3442.2441
Slightly volatile
Payout Ratio1.911.81660.7631
Slightly volatile
Days Payables Outstanding5.233.54614.4091
Slightly volatile
Income Quality2.161.2941.61
Pretty Stable
Intangibles To Total Assets0.750.71860.6634
Slightly volatile
Net Debt To EBITDA3.743.55791.7394
Slightly volatile
Current Ratio0.961.00682.3692
Slightly volatile
Receivables Turnover12.7612.15578.7572
Slightly volatile
Graham Number27.826.479224.4177
Slightly volatile
Shareholders Equity Per Share32.9731.395818.9017
Slightly volatile
Debt To Equity0.510.89360.4284
Slightly volatile
Capex Per Share0.970.92720.564
Slightly volatile
Revenue Per Share54.0451.465632.7531
Slightly volatile
Interest Debt Per Share30.1128.678511.0738
Slightly volatile
Debt To Assets0.220.35360.1975
Slightly volatile
Short Term Coverage Ratios1.371.443545.9753
Slightly volatile
Operating Cycle28.5330.027142.266
Slightly volatile
Price Book Value Ratio4.62.48734.1291
Pretty Stable
Days Of Payables Outstanding5.233.54614.4091
Slightly volatile
Dividend Payout Ratio1.911.81660.7631
Slightly volatile
Pretax Profit Margin0.0880.09960.1211
Slightly volatile
Ebt Per Ebit0.670.96740.9702
Slightly volatile
Effective Tax Rate0.330.25460.2687
Slightly volatile
Company Equity Multiplier1.52.52711.9699
Slightly volatile
Long Term Debt To Capitalization0.250.35580.2077
Slightly volatile
Total Debt To Capitalization0.290.47190.2767
Slightly volatile
Debt Equity Ratio0.510.89360.4284
Slightly volatile
Quick Ratio0.961.00682.3692
Slightly volatile
Net Income Per E B T0.180.19360.4028
Slightly volatile
Cash Ratio0.240.25581.0882
Slightly volatile
Days Of Sales Outstanding28.5330.027142.266
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.81250.929
Slightly volatile
Price To Book Ratio4.62.48734.1291
Pretty Stable
Fixed Asset Turnover2.742.881111.1126
Slightly volatile
Debt Ratio0.220.35360.1975
Slightly volatile
Price Sales Ratio2.931.51733.5845
Slightly volatile
Asset Turnover0.620.64870.8902
Slightly volatile
Gross Profit Margin0.290.20150.2273
Pretty Stable
Price Fair Value4.62.48734.1291
Pretty Stable

US Physicalrapy Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap165.1 M157.2 M163.8 M
Slightly volatile
Enterprise Value151.5 M144.3 M150.3 M
Slightly volatile

USPH Fundamental Market Drivers

Forward Price Earnings29.9401
Cash And Short Term Investments35.6 M

USPH Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's revenue or net income, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue3.3 M1.9 M
Total Revenue781 M820 M
Cost Of Revenue623.6 M654.8 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.10  0.12 
Capex To Revenue 0.02  0.02 
Revenue Per Share 51.47  54.04 
Ebit Per Revenue 0.10  0.07 

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
How To Invest In USPH
Details
Is USPH Stock a good investment?
Details
What is US Physicalrapy's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is there potential for Health Care Providers & Services market expansion? Will USPH introduce new products? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.236
Dividend Share
1.8
Earnings Share
2.37
Revenue Per Share
50.962
Quarterly Revenue Growth
0.125
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, US Physicalrapy's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY